Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medulloblastomas and central nervous system primitive neuroectodermal tumors.

Thomas W McLean1

  • 1Department of Pediatrics, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. tmclean@wfubmc.edu

Current Treatment Options in Oncology
|October 31, 2003
PubMed
Summary

Advances in treating medulloblastoma and primitive neuroectodermal tumors (PNETs) improve survival, but prognosis varies, especially in infants and metastatic cases. Current treatment involves surgery, radiation, and chemotherapy, with clinical trials recommended for eligible patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Effectiveness of Emicizumab in People With Haemophilia A Enrolled in the ATHN 7 Haemophilia Natural History Study.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States.

Pediatric blood & cancer·2025
Same author

Hypoalbuminemia and Nutritional Status in Children With Cancer.

Pediatric blood & cancer·2024
Same author

Designing Patient-Reported Measures of Fertility: Cognitive Interview Findings from Adolescents and Young Adults with Cancer.

Journal of adolescent and young adult oncology·2024
Same author

Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study.

Pediatric blood & cancer·2023
Same author

Practice Variations in Managing Infantile Hemangiomas.

Journal of pediatric hematology/oncology·2023

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Cancer Therapeutics

Background:

  • Medulloblastoma and primitive neuroectodermal tumors (PNETs) are common pediatric central nervous system neoplasms.
  • Significant treatment advances have been made over the last 30 years, yet prognosis remains variable, particularly for infants and those with metastatic disease.

Purpose of the Study:

  • To outline current therapeutic strategies for medulloblastoma and PNETs.
  • To emphasize the importance of clinical trials and multimodal treatment approaches.

Main Methods:

  • Surgical resection as a primary treatment modality.
  • Radiation therapy protocols tailored to risk stratification (average vs. high-risk).
  • Intensive multimodal chemotherapy following radiation therapy.

Related Experiment Videos

Main Results:

  • Medulloblastoma and PNETs demonstrate responsiveness to radiation and chemotherapy.
  • Risk-stratified craniospinal irradiation doses are defined for average-risk (23.4 Gy + 32.4 Gy boost) and high-risk (36 Gy + 19.8 Gy boost) patients.
  • Multimodal therapy, including surgery, radiation, and chemotherapy, is crucial for improving outcomes.

Conclusions:

  • Maximal surgical resection, followed by appropriate radiation and chemotherapy, forms the cornerstone of medulloblastoma and PNET treatment.
  • Clinical trial participation is strongly encouraged for eligible patients to further refine treatment strategies and reduce long-term sequelae.
  • Despite advances, ongoing research is vital to improve survival rates and minimize treatment-related toxicities in pediatric CNS tumors.